Fredun Pharmaceuticals Ltd — Updates, 31-05-2025: Company Update

Fredun Pharmaceuticals has announced a board meeting to approve the re-appointment of key auditors for FY 2025-26. M/s. Kala Agarwal will continue as Secretarial Auditor for five years, bringing over 20 years of expertise in corporate law and compliance. M/s. Nikhil Maniar & Associates has been appointed Internal Auditor, providing audit, assurance, and tax advisory services. M/s. Joshi Apte & Associates will serve as Cost Auditor, offering specialized cost audit and consultancy services across industries including pharmaceuticals. These appointments reinforce the company’s focus on compliance and governance integrity.